Issue link: https://uberflip.scri.com/i/1529641
1125/24SCR018-7/R3 Abstract & Presentation Calendar ASH® 2024 1 Saturday Sunday Monday SATURDAY, DECEMBER 7 TH 9:30am - 5:00pm Pacific Time Time Presentation Time Session Location Presentation Type Abstract Number Presentation Title 1st Author *SCRI First Author in Bold SCRI-Affiliated Coauthors Session Name 9:30 - 11:00am 9:30am Marriott Marquis San Diego Marina, Pacific Ballroom Salons 18-19 Oral 67 Rapcabtagene Autoleucel (YTB323) in Patients (Pts) with Relapsed/ Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL): Phase II Trial Clinical Update Riedell PA Ramakrishnan A Aggressive Lymphomas: Cellular Therapies: Novel Strategies for Cell Therapies in Aggressive Lymphomas 9:30 - 11:00am 9:45am San Diego Convention Center, Ballroom 20CD Oral 98 Dynamics of Overall and Organ- Specific Responses to Axatilimab in Chronic Graft-Versus-Host Disease: Analysis from the Agave-201 Study Choe H Farhadfar H Allogeneic Transplantation: Acute and Chronic GVHD and Immune Reconstitution: Predicting and Treating Acute and Chronic GVHD 2:00 - 3:30pm 2:30pm San Diego Convention Center, Ballroom 20CD Oral 213 Phase 1 Results: First-in-Human Phase 1/2 Study of the Menin-MLL Inhibitor Enzomenib (DSP-5336) in Patients with Relapsed or Refractory Acute Leukemia Zeidner JF Keiffer G, Strickland SA, Eghtedar A Acute Myeloid Leukemias: Investigational Drug and Cellular Therapies: Menin Inhibitors in AML 2:00 - 3:30pm 2:45pm San Diego Convention Center, Ballroom 20CD Oral 214 Ziftomenib Combined with Intensive Induction (7+3) in Newly Diagnosed NPM1-m or KMT2A-r Acute Myeloid Leukemia: Interim Phase 1a Results from KOMET-007 Zeidan AM Strickland SA, Rotta M Acute Myeloid Leukemias: Investigational Drug and Cellular Therapies: Menin Inhibitors in AML 4:00 - 5:30pm 5:00pm Marriott Marquis, Marriott Grand Ballroom 11-13 Oral 341 Escalating Doses of AZD0486, a Novel CD19xCD3 T-Cell Engager, Result in High Complete Remissions with Rapid Clearance of Minimal Residual Disease in Patients with Relapsed/Refractory Follicular Lymphoma Hou JZ Ramakrishnan A Mantle Cell, Follicular, Waldenstrom's, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological: Novel Treatment Strategies and New Data on Old Standards for Follicular Lymphoma